Manufacturing is in process
 |
| Figure 1: 500 GPM AOS Prototype (4 cylinders) |
Westminster, CA – March 17, 2020 – BioLargo, Inc.
(OTCQB:BLGO), developer of sustainable technologies and a full-service environmental
engineering company, announced that it has designed and is manufacturing a
scaled up commercial prototype of its proprietary Advanced Oxidation System
(AOS) that is capable of processing 500 gallons of water per minute (“GPM”), a
volume commensurate with the flowrate requirements of many commercial
applications.
The new design utilizes the Spiral AOS geometry in order to
achieve greater flowrate capacity without sacrificing size, and is expected to
be the most energy-efficient model of the AOS technology to-date. This new design
is modular and easily scalable by increasing or decreasing the number of AOS
spiral reactors (the long horizontal cylinders seen here), each of which is
expected to be capable of 125 GPM.
The 500 GPM AOS unit (seen in Figure 1) is suitable for use
in many commercial settings, including poultry processing and the stormwater
treatment and water reuse market, where the company is currently pursuing
commercial piloting opportunities, as well as secondary markets which include stormwater,
food & beverage, industrial and oil & gas, agriculture, and municipal.
Dr. Richard Smith, President of Biolargo Water remarked, “BioLargo’s
engineering team has made it possible to accelerate the transformation of the
AOS from a small, bench-scale unit to a pilot unit, and now to a commercially
viable large-scale water treatment system. We are fortunate to have access to
those experienced engineers.”
BioLargo Engineering President Randall Moore, a 20+ year
veteran in delivering environmental engineering services, commented, “Producing
a 500 GPM AOS system is the next requisite step in the commercialization of the
AOS technology. Moving to this larger scale (approximately one cubic foot per
second) immediately changes the AOS from a research-focused prototype into a
viable, commercial water disinfection option for multiple industries. As a
modular system, much higher flow rates than 500 GPM are possible. A ten by ten
array of 500 GPM AOS units could effectively disinfect 50,000 GPM, needed for
large scale applications such as municipal water treatment plants. This important
scale-up step brings with it a world of opportunity.”
BioLargo, Inc. President & CEO Dennis P. Calvert
commented, “This a momentous day for BioLargo Water and the AOS technology as
it puts behind us the question of whether we can scale the AOS technology to
meet the high volume needs of the very large water treatment market. It also highlights
the collaborative design and manufacturing effort between BioLargo Water and our
engineering team at BLEST.”
BioLargo
Water currently has a crowdfunding opportunity open on the WaterWorks
Crowdfunding platform through its parent company BioLargo Water Investment
Group. To learn more about this opportunity to invest in BioLargo Water, go to www.waterworksfund.com.
About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and
environmental engineering solutions provider driven by a mission to “make life
better”. We feature unique disruptive solutions
to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division
features experienced professional engineers dedicated to integrity, reliability,
and environmental stewardship (www.biolargoengineering.com).
Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne
Clean Industrial Odor Eliminator (www.cupridyne.com),
which eliminates the odor-causing compounds and VOCs rather than masking them,
and is now winning over leading companies in the solid waste handling and
wastewater industries and other industries that contend with malodors and VOCs.
Our subsidiary BioLargo Water (www.biolargowater.ca)
develops the Advanced Oxidation System "AOS," a disruptive industrial
water treatment technology designed to eliminate waterborne pathogens and
recalcitrant contaminants with better energy-efficiency and lower operational
costs than incumbent technologies. We are a minority stockholder of and licensor
to our subsidiary Clyra Medical (www.clyramedical.com),
which features effective and gentle solutions for chronic infected wounds to
promote infection control and regenerative tissue therapy.
About BioLargo Water
BioLargo Water, Inc. is an Alberta-based Canadian
corporation headquartered at Agri-Food Discovery Place located on campus at the
University of Alberta in Edmonton. BioLargo Water, Inc. developed and is
commercializing the Advanced Oxidation System (AOS), a patented and proprietary
technology aimed at providing cost- and energy-efficient treatment of water and
wastewater to enable practical and affordable safe discharge and reuse of
diverse water sources. Learn more at www.biolargowater.com.
BioLargo Water, Inc. is a subsidiary of BioLargo Water Investment Group, Inc.
(BWIG), which a subsidiary of BioLargo, Inc. (www.biolargo.com),
an innovator of technology-based products and environmental engineering solutions
provider driven by a mission to “make life better”. BioLargo features unique disruptive solutions
to deliver clean air, clean water and a clean, safe environment.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release includes “forward-looking statements”
within the meaning of the safe harbor provisions of the United States Private
Securities Litigation Reform Act of 1995. Actual results may differ from
expectations, estimates and projections and, consequently, you should not rely
on these forward-looking statements as predictions of future events. Words such
as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,”
“intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,”
“potential,” “continue,” and similar expressions are intended to identify such
forward-looking statements. These forward-looking statements involve
significant risks and uncertainties that could cause the actual results to
differ materially from the expected results.
No comments:
Post a Comment